Please sign in to follow a disease.
Light Therapy's secret: scientists probe tear changes for dry eye clues
NCT ID NCT07329712
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how low-level light therapy changes tear proteins in people with dry eye disease. Researchers want to understand how the therapy works and find markers that show who will respond well. About 30 adults will have their tears tested before and after treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patient undergoing low level light therapy that met the study inclusion and exclusion
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Must be eligible for, and have consented for low level light therapy 2. Must not have presented to the clinic for an acute eye problem such as visual loss or painful eye 3. Ability to give informed consent. 4. Age more or equals to 21 years old. Exclusion Criteria: 1. Patients who are unable to or decline to give consent. 2. Age less than 21 years old. 3. Patients who presented to the clinic for an acute eye problem such as visual loss or painful eye. 4. Patients not suitable for low level lighttherapy: * Pregnant * Fitted with pacemakers, metal, electrical, acoustic prosthetics * Epilepsy, cardiac rhythm or frequency disorders * Fever, thrombophlebitis or acute phlebitis of the legs, large-sized varicose veins, or venous surgery within 2 months * Uncontrolled hypertension or severe diabetes * Open wounds on eyelid or skin * Evolving cancer or hepatitis * Blood anticoagulant or coagulation defect
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dry eye are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Singapore Eye Research Insititute
RECRUITINGSingapore, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 13-Minute eye exercise routine ease screen strain?
- Gel plug in tear duct tested to keep eyes moist after cataract surgery
- A gel plug for tear ducts may stop post-surgery dry eye
- Can a thymosin beta 4 eye drop soothe dry eye?
- Insulin-spiked eye drops may ease stubborn dry eye in Sjögren's patients
- Can four eye scanners detect how miebo stabilizes tears?